Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Blood glucose levels are maintained by the balance between glucose uptake by peripheral tissues and glucose secretion by the liver. Gluconeogenesis is strongly stimulated during fasting and is aberrantly activated in diabetes mellitus. Here we show that the transcriptional coactivator PGC-1 is strongly induced in liver in fasting mice and in three mouse models of insulin action deficiency: streptozotocin-induced diabetes, ob/ob genotype and liver insulin-receptor knockout. PGC-1 is induced synergistically in primary liver cultures by cyclic AMP and glucocorticoids. Adenoviral-mediated expression of PGC-1 in hepatocytes in culture or in vivo strongly activates an entire programme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading to increased glucose output. Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4alpha (hepatic nuclear factor-4alpha) by PGC-1. These results implicate PGC-1 as a key modulator of hepatic gluconeogenesis and as a central target of the insulin-cAMP axis in liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic gluconeogenesis is promoted by the PKA-mediated phosphorylation of the cAMP response element-binding protein, which in turn upregulates peroxisome proliferator-activated receptor-γ coactivator (PGC)-1.160 Together with the hepatocyte nuclear factor (HNF)-4, PGC-1 induces the transcription of phosphoenolpyruvate carboxykinase,161 which catalyzes the conversion of oxaloacetate into phosphoen”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [161]
In the citing paper
“Previous work has established that repression of either or both co-activators (PGC-1α or PGC-1β) decreases mitochondrial biogenesis and function, elicits cardiomyopathy and impairs de novo glucose production23-25.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [24]
In the citing paper
“In liver PGC-1α is upregulated by fasting and induces a shift in metabolism toward increased glucose output [80].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
In the citing paper
“The metabolic shifts that occur in response to fasting highlight the non-equivalence of PGC-1α function in distinct tissues.”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationThe coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“The liver-specific insulin-receptor knockout (LIRKO) mouse is a unique model of hepato-specific insulin resistance in the liver, and is associated with impaired glucose tolerance and the failure of insulin to suppress hepatic glucose productio”
BackgroundSelf-citationPeroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195 · cited 1×
“This region of PGC-1 has previously been shown to mediate ligand-dependent interactions with the activation function-2 (AF-2) domains of several nuclear receptors, including oestrogen receptor-α (ERα), peroxisome proliferator-activated receptor-α (PPARα) and glucocorticoid recepto”
BackgroundMolecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · cited 1×
“Glycogenolysis occurs more rapidly, beginning within 2–3 h after a meal in humans, but gluconeogenesis assumes a much greater importance with prolonged fastin”
BackgroundSelf-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“PGC-1 coactivates HNF-4α and the glucocorticoid receptor The mechanisms underlying the transcriptional activation of the gluconeogenic enzyme PEPCK have been extensively studie”
Background(1997) · Diabetes reviews · Cited by 671
Cited by
Items 201–300 of 1,002
Fibroblast growth factor 21: from pharmacology to physiology
Kliewer, S. A., & Mangelsdorf, D. J. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28449b · Cited by 219
Chakravarty, K., Cassuto, H., Reshef, L., & Hanson, R. W. (2005) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230590935479 · Cited by 219
“Glucagon induces the levels of PGC-1α mRNA, and over-expression of PGC-1α stimulates transcription of the gene for PEPCK-C (Yoon et al., 2001).”
BackgroundInfluentialHousley, M. P., Udeshi, N. D., Rodgers, J. T., Shabanowitz, J., Puigserver, P., Hunt, D. F., & Hart, G. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808890200 · Cited by 216
Self-citationSong, S., Attia, R. R., Connaughton, S., Niesen, M. I., Ness, G. C., Elam, M. B., Hori, R. T., Cook, G. A., & Park, E. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.05.019 · Cited by 215
“In the liver, PGC-1α abundance is increased in fasting and diabetes (Yoon et al., 2001).”
BackgroundCalcium Signaling through CaMKII Regulates Hepatic Glucose Production in Fasting and Obesity
Ozcan, L., Wong, C. C. L., Li, G., Xu, T., Pajvani, U., Park, S. K. R., Wronska, A., Chen, B.-X., Marks, A. R., Fukamizu, A., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.002 · Cited by 215
Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues
Fulco, M., & Sartorelli, V. (2008) · Cell Cycle · doi:10.4161/cc.7.23.7164 · Cited by 215
Wang, Q., Jiang, L., Wang, J., Li, S., Yu, Y., You, J., Zeng, R., Gao, X., Rui, L., Li, W., et al. (2009) · Hepatology · doi:10.1002/hep.22774 · Cited by 213
Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null mice
Bernal-Mizrachi, C., Weng, S., Feng, C., Finck, B. N., Knutsen, R. H., Leone, T. C., Coleman, T., Mecham, R. P., Kelly, D. P., & Semenkovich, C. F. (2003) · Nature Medicine · doi:10.1038/nm898 · Cited by 212
Protective effects and mechanisms of sirtuins in the nervous system
Zhang, F., Wang, S., Gan, L., Vosler, P. S., Gao, Y., Zigmond, M. J., & Chen, J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.001 · Cited by 211
MEIRHAEGHE, A., CROWLEY, V., LENAGHAN, C., LELLIOTT, C., GREEN, K., STEWART, A., HART, K., SCHINNER, S., SETHI, J. K., YEO, G., et al. (2003) · Biochemical Journal · doi:10.1042/bj20030200 · Cited by 210
PGC-1 coactivators in the control of energy metabolism
Liu, C., & Lin, J. D. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr007 · Cited by 210
Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes
Wang, Y., Li, G., Goode, J., Paz, J. C., Ouyang, K., Screaton, R., Fischer, W. H., Chen, J., Tabas, I., & Montminy, M. (2012) · Nature · doi:10.1038/nature10988 · Cited by 210
Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes
Sharabi, K., Lin, H., Tavares, C. D. J., Dominy, J. E., Camporez, J. P., Perry, R. J., Schilling, R., Rines, A. K., Lee, J., Hickey, M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.001 · Cited by 210
Self-citationDe Fabiani, E., Mitro, N., Gilardi, F., Caruso, D., Galli, G., & Crestani, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305079200 · Cited by 210
Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma
Yin, P. H., Lee, H. C., Chau, G. Y., Wu, Y. T., Li, S. H., Lui, W. Y., Wei, Y. H., Liu, T. Y., & Chi, C. W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601838 · Cited by 209
“In addition, it has been demonstrated that PGC-1 is required for mitochondrial biogenesis (Wu et al, 1999) and for the regulation of hepatic gluconeogenesis (Yoon et al, 2001).”
BackgroundNakagawa, Y., Shimano, H., Yoshikawa, T., Ide, T., Tamura, M., Furusawa, M., Yamamoto, T., Inoue, N., Matsuzaka, T., Takahashi, A., et al. (2006) · Nature Medicine · doi:10.1038/nm1334 · Cited by 209
Understanding nuclear receptor form and function using structural biology
Rastinejad, F., Huang, P., Chandra, V., & Khorasanizadeh, S. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0173 · Cited by 207
“Targets of this receptor include genes involved in gluconeogenesis and lipid metabolism (Yoon et al .”
BackgroundIdentification of small-molecule antagonists that inhibit an activator:coactivator interaction
Best, J. L., Amezcua, C. A., Mayr, B., Flechner, L., Murawsky, C. M., Emerson, B., Zor, T., Gardner, K. H., & Montminy, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406374101 · Cited by 207
Multidomain integration in the structure of the HNF-4α nuclear receptor complex
Chandra, V., Huang, P., Potluri, N., Wu, D., Kim, Y., & Rastinejad, F. (2013) · Nature · doi:10.1038/nature11966 · Cited by 206
“All HNF4α (human) constructs including FL (1-464), ΔABΔF (46-368), ΔF (1-368), ΔAB (46-464), and DBD (46-126), and others were expressed from pET46 Ek/LIC vector in BL21(DE3) E.”
MethodIdentification of an Endogenous Ligand Bound to a Native Orphan Nuclear Receptor
Yuan, X., Ta, T. C., Lin, M., Evans, J. R., Dong, Y., Bolotin, E., Sherman, M. A., Forman, B. M., & Sladek, F. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005609 · Cited by 205
“No positive effect of LA was observed on full length HNF4a2 with or without expression of PGC1a (data not shown), a key coactivator that mediates HNF4a activity in the liver [43].”
Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production
Chutkow, W. A., Patwari, P., Yoshioka, J., & Lee, R. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708169200 · Cited by 204
Semple, R. K., Crowley, V. C., Sewter, C. P., Laudes, M., Christodoulides, C., Considine, R. V., Vidal-Puig, A., & O'Rahilly, S. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802482 · Cited by 203
Argemi, J., Latasa, M. U., Atkinson, S. R., Blokhin, I. O., Massey, V., Gue, J. P., Cabezas, J., Lozano, J. J., Van Booven, D., Bell, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11004-3 · Cited by 203
Control of hepatitis B virus at the level of transcription
Quasdorff, M., & Protzer, U. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01315.x · Cited by 202
The hitchhiker’s guide to PGC-1α isoform structure and biological functions
Martínez-Redondo, V., Pettersson, A. T., & Ruas, J. L. (2015) · Diabetologia · doi:10.1007/s00125-015-3671-z · Cited by 202
“Some of the signalling pathways controlling PGC-1α gene expression involve calcium signalling [12], calcineurin A [13], cyclic AMP [14] and 5′ AMP-activated protein kinase (AMPK) [15].”
BackgroundSteinbrenner, H., Speckmann, B., Pinto, A., & Sies, H. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-002fr · Cited by 202
Neural connections between the hypothalamus and the liver
Uyama, N., Geerts, A., & Reynaert, H. (2004) · The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology · doi:10.1002/ar.a.20086 · Cited by 201
Selesniemi, K., Lee, H.-J., Muhlhauser, A., & Tilly, J. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018793108 · Cited by 201
“In addition, PGC-1α is thought to mediate gluconeogenesis in response to CR, although evidence for this conclusion derives from studies of acute fasting of animals or overexpression of PGC-1α using adenoviruses (25, 44) and not CR.”
BackgroundMiao, J., Fang, S., Bae, Y., & Kemper, J. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510713200 · Cited by 200
PKA-dependent regulation of the histone lysine demethylase complex PHF2–ARID5B
Baba, A., Ohtake, F., Okuno, Y., Yokota, K., Okada, M., Imai, Y., Ni, M., Meyer, C. A., Igarashi, K., Kanno, J., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2228 · Cited by 199
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5
Caton, P. W., Nayuni, N. K., Kieswich, J., Khan, N. Q., Yaqoob, M. M., & Corder, R. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0345 · Cited by 198
“…of CREB at Ser133 and formation of the TORC2–CREB–CBP complex and subsequent induction of peroxisome proliferator-activated receptor-g coactivator-1a (PGC1a or PPARGC1A as listed in the MGI Database) an essential coactivator of Pck1 (Yoon et al. 2001, Koo et al. 2005, Dentin et al. 2007).”
BackgroundIncreased Dietary Protein Modifies Glucose and Insulin Homeostasis in Adult Women during Weight Loss
Layman, D. K., Shiue, H., Sather, C., Erickson, D. J., & Baum, J. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.2.405 · Cited by 197
“Investigators have shown that high CHO feeding or elevated insulin result in down-regulation of hepatic gluconeogenesis on the basis of measurements of flux (16) as well as down-regulation of gene expression of key regulatory enzymes (41).”
Willy, P. J., Murray, I. R., Qian, J., Busch, B. B., Stevens, W. C., Martin, R., Mohan, R., Zhou, S., Ordentlich, P., Wei, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401420101 · Cited by 196
Medina-Gomez, G., Gray, S., & Vidal-Puig, A. (2007) · Public Health Nutrition · doi:10.1017/s1368980007000614 · Cited by 195
“In the liver, PGC1 a integrates the metabolic adaptation of the rodent liver to fasting by inducing gluconeogenic enzymes 50,53 , thereby enhancing glucose output.”
Iizuka, K., Miller, B., & Uyeda, K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00027.2006 · Cited by 195
Jitrapakdee, S. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.001 · Cited by 195
Regulation of Hepatocyte Nuclear Factor 4α-mediated Transcription
Gonzalez, F. J. (2008) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.23.2 · Cited by 194
Regulation of Hepatic Gluconeogenesis by an ER-Bound Transcription Factor, CREBH
Lee, M.-W., Chanda, D., Yang, J., Oh, H., Kim, S. S., Yoon, Y.-S., Hong, S., Park, K.-G., Lee, I.-K., Choi, C. S., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.016 · Cited by 194
“PGC-1a, a major regulator of hepatic glucose metabolism (Herzig et al., 2001; Yoon et al., 2001), was also involved in the regulation of CREBH by inducing its expression.”
InfluentialJeninga, E. H., Schoonjans, K., & Auwerx, J. (2010) · Oncogene · doi:10.1038/onc.2010.206 · Cited by 193
“The expression and activity of PGC1a is regulated by both cell-autonomous factors, such as AMP-activated kinase (AMPK) and mTOR (Herzig et al., 2001; Yoon et al., 2001; Canto et al., 2009), as well as by systemic factors of hormonal origin, such as insulin, glucagon and glucocorticoids and…”
BackgroundInfluentialDominy, J. E., Lee, Y., Gerhart-Hines, Z., & Puigserver, P. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.023 · Cited by 192
“This list includes PPARα, glucocorticoid receptor, hepatic nuclear factor-4α, members of the estrogen related receptor (ERR) family, myocyte enhancer factor 2, nuclear respiratory factors 1 and 2, FoxO1, and YY1 [2-6].”
BackgroundSelf-citationPPAR control: it's SIRTainly as easy as PGC
Sugden, M. C., Caton, P. W., & Holness, M. J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0359 · Cited by 192
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones
Geisler, C. E., & Renquist, B. J. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0513 · Cited by 191
Kurlawalla-Martinez, C., Stiles, B., Wang, Y., Devaskar, S. U., Kahn, B. B., & Wu, H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2498-2510.2005 · Cited by 191
“However, resistin has also been shown to impair glucose transport in cultured adipocytes (61, 75) and myocytes (42, 53).”
BackgroundMorrison, J. L., Duffield, J. A., Muhlhausler, B. S., Gentili, S., & McMillen, I. C. (2010) · Pediatric Nephrology · doi:10.1007/s00467-009-1407-3 · Cited by 189
“Cortisol plays a key role in the upregulation of hepatic PEPCK activity and expression in the late gestation fetus [60, 61] and so the increase in hepatic 11βHSD1 mRNA expression and intra-hepatic cortisol production may lead to an increase in PEPCK mRNA expression.”
BackgroundInfluentialKang, S., Dahl, R., Hsieh, W., Shin, A., Zsebo, K. M., Buettner, C., Hajjar, R. J., & Lebeche, D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.705012 · Cited by 189
“Besides regulation of mitochondrial biogenesis and respiration, PGC1 is also known to stimulate hepatic gluconeogenesis (36).”
BackgroundThe Search for Safer Glucocorticoid Receptor Ligands
Rosen, J., & Miner, J. N. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0002 · Cited by 184
“We examined GR cofactor recruitment induced by AL-438 using two cofactors: peroxisome proliferator-activated receptor- coactivator-1 (PGC-1), which is involved in hepatic glucose production; and GRIP-1, which appears to play a role in GR-mediated transcriptional repression of proinflammatory genes (135, 136).”
MethodNrf2 Represses FGF21 During Long-Term High-Fat Diet–Induced Obesity in Mice
Chartoumpekis, D. V., Ziros, P. G., Psyrogiannis, A. I., Papavassiliou, A. G., Kyriazopoulou, V. E., Sykiotis, G. P., & Habeos, I. G. (2011) · Diabetes · doi:10.2337/db11-0112 · Cited by 184
“Notably, Nrf2-KO mice on an HFD had significantly higher mRNA levels of PGC-1a and PEPCK than WT mice in both the liver (P , 0.001 and P , 0.05, respectively) and WAT (P , 0.001 for both genes).”
BackgroundInfluentialHondares, E., Mora, O., Yubero, P., de la Concepción, M. R., Iglesias, R., Giralt, M., & Villarroya, F. (2006) · Endocrinology · doi:10.1210/en.2006-0070 · Cited by 183
“It is required for efficient activation of gluconeogenesis in the liver (5), and it promotes mitochondrial biogenesis in skeletal muscle (6).”
BackgroundErkens, T., Van Poucke, M., Vandesompele, J., Goossens, K., Van Zeveren, A., & Peelman, L. J. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-41 · Cited by 183
“PPARGC1A plays an important role in adipogenesis and adipocyte differentiation [11], mitochondrial biogenesis and respiration [9,12], and hepatic gluconeogenesis [13].”
BackgroundPPARα is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue
Lee, Y., Yu, X., Gonzales, F., Mangelsdorf, D. J., Wang, M.-Y., Richardson, C., Witters, L. A., & Unger, R. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182420899 · Cited by 181
Limesand, S. W., Rozance, P. J., Smith, D., & Hay, W. W. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00459.2007 · Cited by 181
Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice
Bugger, H., Chen, D., Riehle, C., Soto, J., Theobald, H. A., Hu, X. X., Ganesan, B., Weimer, B. C., & Abel, E. D. (2009) · Diabetes · doi:10.2337/db09-0259 · Cited by 180
“For example, myocardial fatty acid oxidation (FAO) and hepatic gluconeogenesis are increased (3,4).”
BackgroundGiri, S., Rattan, R., Haq, E., Khan, M., Yasmin, R., Won, J.-S., Key, L., Singh, A. K., & Singh, I. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-31 · Cited by 180
Gilde, A. J., & Van Bilsen, M. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01161.x · Cited by 178
The FoxO transcription factors and metabolic regulation
Nakae, J., Oki, M., & Cao, Y. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.025 · Cited by 176
Samuel, V. T., Beddow, S. A., Iwasaki, T., Zhang, X.-M., Chu, X., Still, C. D., Gerhard, G. S., & Shulman, G. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812547106 · Cited by 176
Regulation and Co‐Ordination of Nuclear Gene Expression During Mitochondrial Biogenesis
Goffart, S., & Wiesner, R. J. (2003) · Experimental Physiology · doi:10.1113/eph8802500 · Cited by 175
Wnt Signaling Regulates Hepatic Metabolism
Liu, H., Fergusson, M. M., Wu, J. J., Rovira, I. I., Liu, J., Gavrilova, O., Lu, T., Bao, J., Han, D., Sack, M. N., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001249 · Cited by 174
“This is consistent with previous reports suggesting that nutrient control of PGC-1a activity occurs predominantly through transcriptional regulation and posttranslational modification rather than through alteration in subcellular distribution (25, 27, 30).”
MethodSteinbrenner, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.016 · Cited by 172
Li, S., Liu, C., Li, N., Hao, T., Han, T., Hill, D. E., Vidal, M., & Lin, J. D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.013 · Cited by 169
“PGC-1a regulates several major metabolic pathways, including mitochondrial OX- PHOS (Lehman et al., 2000; St-Pierre et al., 2003; Wu et al., 1999), hepatic gluconeogenesis (Herzig et al., 2001; Yoon et al., 2001), and reactive oxygen species metabolism (St-Pierre et al., 2006; Valle et al., 2005).”
BackgroundMethodThe circulating metabolome of human starvation
Steinhauser, M. L., Olenchock, B. A., O’Keefe, J., Lun, M., Pierce, K. A., Lee, H., Pantano, L., Klibanski, A., Shulman, G. I., Clish, C. B., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121434 · Cited by 152
Ye, Q., Liu, Y., Zhang, G., Deng, H., Wang, X., Tuo, L., Chen, C., Pan, X., Wu, K., Fan, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37142-3 · Cited by 168
Gusdon, A. M., Song, K.-X., & Qu, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/637027 · Cited by 168
“However, PGC-1α has also been shown to act downstream of cAMP response binding protein (CREB) to induce gluconeogenesis [226] in part due to its ability to activate phosphoenolpyruvate carboxykinase (PEPCK) and glucose6-phosphatase [227].”
Laganière, J., Tremblay, G. B., Dufour, C. R., Giroux, S., Rousseau, F., & Giguère, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313543200 · Cited by 167
PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
Sen, N., Satija, Y. K., & Das, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.044 · Cited by 166
“…glucose starvation, we found both p53 and PGC-1a levels to be significantly induced as previously reported (Jones et al., 2005; Okoshi et al., 2008; Yoon et al., 2001; Jager et al., 2007), but under similar conditions only p53 was induced in PGC-1a knockdown cells (Figure 1C). ular Cell 44,…”
Wesolowski, S. R., Regnault, T. R. H., Brown, L. D., Rozance, P. J., Keng, J. A., Roper, M. D., Wilkening, R. B., Hay, W. W., & Friedman, J. E. (2009) · Endocrinology · doi:10.1210/en.2008-1789 · Cited by 174
Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma
Ma, R., Zhang, W., Tang, K., Zhang, H., Zhang, Y., Li, D., Li, Y., Xu, P., Luo, S., Cai, W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3508 · Cited by 163
Endothelial PGC-1α Mediates Vascular Dysfunction in Diabetes
Sawada, N., Jiang, A., Takizawa, F., Safdar, A., Manika, A., Tesmenitsky, Y., Kang, K.-T., Bischoff, J., Kalwa, H., Sartoretto, J. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.014 · Cited by 163
“In hepatocytes, PGC-1a activates a gluconeogenic program in response to glucagon and low levels of insulin (Herzig et al., 2001; Yoon et al., 2001).”
BackgroundPGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
“In liver PGC-1α is upregulated by fasting and induces a shift in metabolism toward increased glucose output [80].”
Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease
Chopra, A. R., Louet, J.-F., Saha, P., An, J., DeMayo, F., Xu, J., York, B., Karpen, S., Finegold, M., Moore, D., et al. (2008) · Science · doi:10.1126/science.1164847 · Cited by 161
Self-citationShaping the role of mitochondria in the pathogenesis of Huntington's disease
Costa, V., & Scorrano, L. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.65 · Cited by 161
“PGC1 a is a transcriptional coactivator involved in adaptive thermogenesis (Lin et al , 2005; Puigserver, 2005), b -oxidation of fatty acids, glucose metabolism (Yoon et al , 2001) and induction of mitochondrial biogenesis.”
Adiponectin signaling in the liver
Combs, T. P., & Marliss, E. B. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9280-6 · Cited by 148
“4α (HNF4α) and the forkhead familymember Foxo1 driving G6Pase and PEPCK mRNA expression [57].”
BackgroundInsulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein
Zhou, X., Shibusawa, N., Naik, K., Porras, D., Temple, K. A., Ou, H., Kaihara, K. A., Roe, M. W., Brady, M., & Wondisford, F. E. (2004) · Nature Medicine · doi:10.1038/nm1050 · Cited by 160
Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance
Kumashiro, N., Beddow, S. A., Vatner, D. F., Majumdar, S. K., Cantley, J. L., Guebre-Egziabher, F., Fat, I., Guigni, B., Jurczak, M. J., Birkenfeld, A. L., et al. (2013) · Diabetes · doi:10.2337/db12-1311 · Cited by 152
“Increased hepatic gluconeogenesis is often ascribed to transcriptional regulation of two key gluconeogenic enzymes, PEPCK and G6PC, via an intricate web of transcriptional factors and cofactors (8-12).”
BackgroundPüschel, G. P., Klauder, J., & Henkel, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154358 · Cited by 344
Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1
Gosis, B. S., Wada, S., Thorsheim, C., Li, K., Jung, S., Rhoades, J. H., Yang, Y., Brandimarto, J., Li, L., Uehara, K., et al. (2022) · Science · doi:10.1126/science.abf8271 · Cited by 159
“Gluconeogenic targets of PGC-1a (34) did not show increased expression in Flcn KO livers (fig.”
BackgroundEstrogen-related Receptors Stimulate Pyruvate Dehydrogenase Kinase Isoform 4 Gene Expression
Zhang, Y., Ma, K., Sadana, P., Chowdhury, F., Gaillard, S., Wang, F., McDonnell, D. P., Unterman, T. G., Elam, M. B., & Park, E. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608657200 · Cited by 159
Assifi, M. M., Suchankova, G., Constant, S., Prentki, M., Saha, A. K., & Ruderman, N. B. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00144.2005 · Cited by 155
“the latter possibility, decreases in PGC1 mRNA and protein abundance have been reported to occur in liver in the fed state (38, 57), and the mRNA of CPT I, which is also under the control of PGC1 and PPAR (26), has been shown to diminish during refeeding after a fast (28, 46).”
BackgroundTranscriptional coactivator PGC-1α regulates chondrogenesis via association with Sox9
Kawakami, Y., Tsuda, M., Takahashi, S., Taniguchi, N., Esteban, C. R., Zemmyo, M., Furumatsu, T., Lotz, M., Belmonte, J. C. I., & Asahara, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407510102 · Cited by 154
Sirtuins and Insulin Resistance
Zhou, S., Tang, X., & Chen, H.-Z. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00748 · Cited by 142
Rapid exercise-induced changes in PGC-1α mRNA and protein in human skeletal muscle
Mathai, A. S., Bonen, A., Benton, C. R., Robinson, D. L., & Graham, T. E. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00847.2007 · Cited by 158
Mitochondrial Roles and Cytoprotection in Chronic Liver Injury
Degli Esposti, D., Hamelin, J., Bosselut, N., Saffroy, R., Sebagh, M., Pommier, A., Martel, C., & Lemoine, A. (2012) · Biochemistry Research International · doi:10.1155/2012/387626 · Cited by 158
“PGC-1 alpha is present at low but inducible levels in the liver where it also regulates most of the metabolic pathways, including gluconeogenesis, fatty acid β-oxidation, ketogenesis and heme biosynthesis (Figure 4) [90–93].”
BackgroundRole of Forkhead Box O (FOXO) transcription factor in aging and diseases
Tia, N., Singh, A. K., Pandey, P., Azad, C. S., Chaudhary, P., & Gambhir, I. S. (2018) · Gene · doi:10.1016/j.gene.2018.01.051 · Cited by 158
Kwon, H.-S., Huang, B., Unterman, T. G., & Harris, R. A. (2004) · Diabetes · doi:10.2337/diabetes.53.4.899 · Cited by 158
Hirata, H., Sugimachi, K., Komatsu, H., Ueda, M., Masuda, T., Uchi, R., Sakimura, S., Nambara, S., Saito, T., Shinden, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2601 · Cited by 150
PGC-1α, glucose metabolism and type 2 diabetes mellitus
Wu, H., Deng, X., Shi, Y., Su, Y., Wei, J., & Duan, H. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0021 · Cited by 167
“Full transcriptional activation of the PEPCK promoter requires coactivation of the HNF-4α by PGC-1α (Yoon et al. 2001).”
BackgroundRadish (Raphanus sativus) and Diabetes
Banihani, S. (2017) · Nutrients · doi:10.3390/nu9091014 · Cited by 150
“This process may postpone the development of aging diseases, including type 2 diabetes [4,60].”
BackgroundInteraction between Corticosterone and Insulin in Obesity: Regulation of Lard Intake and Fat Stores
la Fleur, S. E., Akana, S. F., Manalo, S. L., & Dallman, M. F. (2004) · Endocrinology · doi:10.1210/en.2003-1359 · Cited by 155
Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer
Jones, L. W., Viglianti, B. L., Tashjian, J. A., Kothadia, S. M., Keir, S. T., Freedland, S. J., Potter, M. Q., Jung Moon, E., Schroeder, T., Herndon, J. E., et al. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00424.2009 · Cited by 149
“Homogenized tumors from both groups were analyzed using commercially available ELISAs for content of VEGF (R&D Systems, kit DVE00) and hypoxia-inducible factor (HIF)-1, (Panomics, Fremont, CA), whereas Western blotting was used to assess AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated recepto…”
MethodHammarstedt, A., Jansson, P.-A., Wesslau, C., Yang, X., & Smith, U. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00014-7 · Cited by 156
LIM, J., Lee, H., HOJUNG, M., & Song, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.004 · Cited by 168
Kamashev, D., Vitoux, D., & de Thé, H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032226 · Cited by 153
“cAMP greatly enhances expression of the PGC-1 coactivator (44, 45) and recent reports have pointed to dynamic equilibrium between corepressor, coactivators, and RA-bound conformations of RARA (46), which may explain our findings.”
BackgroundAdministration of Lactobacillus paracasei ameliorates type 2 diabetes in mice
Dang, F., Jiang, Y., Pan, R., Zhou, Y., Wu, S. L., Wang, R., Zhuang, K., Zhang, W., Li, T., & Man, C. (2018) · Food & Function · doi:10.1039/c8fo00081f · Cited by 164
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Larter, C. Z., & Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.030 · Cited by 169
Louet, J.-F., Hayhurst, G., Gonzalez, F. J., Girard, J., & Decaux, J.-F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205087200 · Cited by 150
MicroRNA 33 Regulates Glucose Metabolism
Ramírez, C. M., Goedeke, L., Rotllan, N., Yoon, J.-H., Cirera-Salinas, D., Mattison, J. A., Suárez, Y., de Cabo, R., Gorospe, M., & Fernández-Hernando, C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00016-13 · Cited by 154
Self-citationGSK4112, a Small Molecule Chemical Probe for the Cell Biology of the Nuclear Heme Receptor Rev-erbα
Grant, D., Yin, L., Collins, J. L., Parks, D. J., Orband‐Miller, L. A., Wisely, G. B., Joshi, S., Lazar, M. A., Willson, T. M., & Zuercher, W. J. (2010) · ACS Chemical Biology · doi:10.1021/cb100141y · Cited by 160
Mitochondria and PGC-1α in Aging and Age-Associated Diseases
Wenz, T. (2011) · Journal of Aging Research · doi:10.4061/2011/810619 · Cited by 148
Ding, X., Lichti, K., Kim, I., Gonzalez, F. J., & Staudinger, J. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600931200 · Cited by 151
Alternative mRNA Splicing Produces a Novel Biologically Active Short Isoform of PGC-1α
Zhang, Y., Huypens, P., Adamson, A. W., Chang, J. S., Henagan, T. M., Boudreau, A., Lenard, N. R., Burk, D., Klein, J., Perwitz, N., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.037556 · Cited by 148
Metadata
- Authors
- Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., Newgard, C. B., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- The University of Texas Southwestern Medical Center (US)
- Vanderbilt University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6852
- Pages
- 131-138
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1523158326
- Cited by
- 1,821
- References
- 33
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 24 · 2023: 48 · 2022: 48 · 2021: 68 · 2020: 63 · 2019: 74 · 2018: 84 · 2017: 67 · 2016: 78 · 2015: 95 · 2014: 75 · 2013: 98 · 2012: 104
- FWCI
- 23.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1, hepatic gluconeogenesis, transcriptional coactivator, fasting, insulin resistance, diabetes mellitus, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, glucocorticoid receptor, HNF4α, cyclic AMP, ob/ob mice, streptozotocin-induced diabetes
- MeSH terms
- Cyclic AMP, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Experimental, DNA-Binding Proteins, Fasting, Gluconeogenesis, Hormones, Insulin, Liver, Male, Obesity, Phosphoenolpyruvate Carboxykinase (GTP), Phosphoproteins, Receptors, Glucocorticoid, Receptor, Insulin, RNA, Messenger, Transcription Factors, Tumor Cells, Cultured, 3T3 Cells, Rats, Wistar, Mice, Knockout, Response Elements, Amino Acid Motifs, Mice, Rats, Hepatocyte Nuclear Factor 4, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.